Health Alert:

COVID-19 Information

Brexucabtagene autoleucel (Tecartus)

About This Treatment

Brexucabtagene autoleucel is used to treat cancer. It is made using your own T-cells, a type of white blood cell. Your T-cells will be collected via leukapheresis, a procedure that circulates your blood through a machine and removes some of your T-cells. Your collected T-cells are then genetically modified to recognize your cancer cells and attack them. Brexucabtagene autoleucel contains your modified T-cells and is given to you through the vein (IV).

View the fact sheet about Brexucabtagene autoleucel (PDF).